Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNCMA
2326
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.03M | ﹤0.01% |
49,699
-890
| -2% | -$36.4K |
|
2327
CALL
Genworth Financial
GNW
$3.76B
| $2.02M | ﹤0.01% |
525,800
+95,200
| +22% | +$340K |
|
2328
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$242M
| $2.02M | ﹤0.01% |
8
+2
| +33% | +$769K |
|
2329
CALL
Cboe Global Markets
CBOE
$32.5B
| $2.02M | ﹤0.01% |
18,800
-11,700
| -38% | -$1.15M |
|
2330
Huazhu Hotels Group
HTHT
$13.1B
| $2.02M | ﹤0.01% |
+68,120
| New | +$1.76M |
|
2331
MBIA
MBI
$261M
| $2.02M | ﹤0.01% |
232,207
+72,705
| +46% | +$730K |
|
|
BIG
2332
CALL
DELISTED
Big Lots, Inc.
BIG
| $2.02M | ﹤0.01% |
37,700
+29,000
| +333% | +$1.43M |
|
|
PSB
2333
DELISTED
PS Business Parks, Inc.
PSB
| $2.02M | ﹤0.01% |
15,117
-1,094
| -7% | -$145K |
|
|
WPZ
2334
CALL
DELISTED
Williams Partners L.P.
WPZ
| $2.02M | ﹤0.01% |
51,800
-23,400
| -31% | -$924K |
|
|
SAGE
2335
DELISTED
Sage Therapeutics
SAGE
| $2.01M | ﹤0.01% |
32,293
-148,462
| -82% | -$11.7M |
|
2336
Euronet Worldwide
EEFT
$2.72B
| $2.01M | ﹤0.01% |
21,226
+4,581
| +28% | +$434K |
|
2337
PUT
Canadian Solar
CSIQ
$1.02B
| $2.01M | ﹤0.01% |
119,300
+10,700
| +10% | +$175K |
|
|
HMHC
2338
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2.01M | ﹤0.01% |
166,598
+125,886
| +309% | +$1.42M |
|
|
PMC
2339
DELISTED
PharMerica Corporation
PMC
| $2M | ﹤0.01% |
68,386
+43,694
| +177% | +$1.22M |
|
2340
Benchmark Electronics
BHE
$2.87B
| $2M | ﹤0.01% |
58,552
-13,896
| -19% | -$456K |
|
2341
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.01B
| $2M | ﹤0.01% |
52,300
+5,400
| +12% | +$194K |
|
|
2342
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.01B
| $2M | ﹤0.01% |
52,295
+27,187
| +108% | +$979K |
|
2343
CALL
Trane Technologies
TT
$100B
| $2M | ﹤0.01% |
22,400
+19,000
| +559% | +$1.68M |
|
2344
PUT
Targa Resources
TRGP
$58B
| $2M | ﹤0.01% |
42,200
-26,900
| -39% | -$1.22M |
|
2345
CALL
Edwards Lifesciences
EW
$49.6B
| $1.99M | ﹤0.01% |
54,600
+6,600
| +14% | +$252K |
|
|
AMAG
2346
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.99M | ﹤0.01% |
107,800
+5,400
| +5% | +$101K |
|
|
FIT
2347
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.99M | ﹤0.01% |
285,200
-27,900
| -9% | -$162K |
|
2348
Mercado Libre
MELI
$95.2B
| $1.98M | ﹤0.01% |
7,659
-7,369
| -49% | -$1.95M |
|
2349
Silicon Motion
SIMO
$8.6B
| $1.98M | ﹤0.01% |
41,283
+21,283
| +106% | +$943K |
|
2350
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.46B
| $1.98M | ﹤0.01% |
47,900
-125,300
| -72% | -$4.99M |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.